Sutro Biopharma (STRO) FCF Margin Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) FCF Margin Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sutro Biopharma |
252.04 Mn |
252.04 Mn |
- |
-5,271.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-5,271.00 |
| Sep 30, 2025 |
-66,421.00 |
| Jun 30, 2025 |
-4,679.00 |
| Mar 31, 2025 |
-59,874.00 |
| Dec 31, 2024 |
-38,924.00 |
| Sep 30, 2024 |
-35,909.00 |
| Jun 30, 2024 |
7,013.00 |
| Mar 31, 2024 |
-27,735.00 |
| Dec 31, 2023 |
26,241.00 |
| Sep 30, 2023 |
-9,119.00 |
| Jun 30, 2023 |
-15,986.00 |
| Mar 31, 2023 |
-21,155.00 |
| Dec 31, 2022 |
-19,986.00 |
| Sep 30, 2022 |
39,995.00 |
| Jun 30, 2022 |
12,543.00 |
| Mar 31, 2022 |
-37,613.00 |
| Dec 31, 2021 |
-5,782.00 |
| Sep 30, 2021 |
-102,305.00 |
| Jun 30, 2021 |
23,620.00 |
| Mar 31, 2021 |
3,541.00 |
